Literature DB >> 12103260

Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome.

Francesco Grigioni1, Jean-François Avierinos, Lieng H Ling, Christopher G Scott, Kent R Bailey, A Jamil Tajik, Robert L Frye, Maurice Enriquez-Sarano.   

Abstract

OBJECTIVES: The study was done to define the incidence, determinants and prognostic implications of onset of atrial fibrillation (AF) during follow-up of mitral regurgitation (MR) initially in sinus rhythm.
BACKGROUND: The rates and clinical implications of AF in MR are undefined.
METHODS: We analyzed the occurrence of AF under conservative management in two populations of patients with degenerative MR in sinus rhythm at diagnosis: 1) 360 patients (65 +/- 13 years, 74% men) with MR due to flail leaflets; and 2) 89 residents of Olmsted County, Minnesota (67 +/- 17 years, 56% men) with grade 3 or 4 MR due to simple mitral valve prolapse (MVP) diagnosed echocardiographically.
RESULTS: In patients with MR due to flail leaflets, AF rates at 5 and 10 years were 18 +/- 3% and 48 +/- 6%, respectively, and the linearized rate was 5.0 +/- 0.7% per year. Development of AF during follow-up was independently associated with high risk of cardiac death or heart failure (adjusted risk ratio 2.23, p = 0.025). The AF rate at 10 years was higher in patients >or=65 years (75 +/- 10% vs. 24 +/- 6%, p < 0.0001) and in those with baseline left atrial (LA) dimension >or=50 mm (67 +/- 8% vs. 37 +/- 9%, p < 0.001). In multivariate analysis, independent baseline predictors of AF were age and LA diameter (both p < 0.01). In patients with MR due to MVP, similar rates of AF (41 +/- 7% vs. 44 +/- 6% at nine years, p > 0.50) and predictors of AF (age and LA dimension, both p < 0.006) were noted.
CONCLUSIONS: In patients with degenerative MR in sinus rhythm at diagnosis, the incidence of AF occurring under conservative management is high and similar whether the cause of MR is flail leaflet or simple MVP. After onset of AF, an increased cardiac mortality and morbidity are both observed under conservative management. The risk of AF increases with advancing age and larger LA dimension. These data suggest that the clinical management of MR should take into account the high incidence, excess risk, and predictors of AF.

Entities:  

Mesh:

Year:  2002        PMID: 12103260     DOI: 10.1016/s0735-1097(02)01922-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  66 in total

Review 1.  Cardiac imaging in valvular heart disease.

Authors:  W S Choo; R P Steeds
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 2.  Mitral valve repair: we must do a better job.

Authors:  William F Northrup Iii
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

3.  Prognostic value of exercise tolerance testing in asymptomatic chronic nonischemic mitral regurgitation.

Authors:  Phyllis G Supino; Jeffrey S Borer; Karlheinz Schuleri; Anuj Gupta; Clare Hochreiter; Paul Kligfield; Edmund McM Herrold; Jacek J Preibisz
Journal:  Am J Cardiol       Date:  2007-07-23       Impact factor: 2.778

Review 4.  Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.

Authors:  Mark A Crandall; David J Bradley; Douglas L Packer; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

5.  Is Left Atrial Size a Predictor of Mortality after Coronary Artery Bypass Surgery? A Single Center Study.

Authors:  Khalid S Ibrahim; Fadia A Mayyas; Khalid Kheirallah; Nizar R AlWaqfi; David R Van Wagoner
Journal:  Acta Cardiol Sin       Date:  2017-03       Impact factor: 2.672

6.  Classification, Etiology and Clinical Evaluation of Atrial Fibrillation.

Authors:  Ermengol Valles; Francis E Marchlinski
Journal:  J Atr Fibrillation       Date:  2008-05-16

7.  Management of asymptomatic, severe mitral regurgitation.

Authors:  Dina M Sparano; R Parker Ward
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

8.  Can we change the operative criteria for the MAZE procedure combined with valve surgery in the era of radiofrequency devices?

Authors:  Suguru Kubota; Hiroshi Sugiki; Satoru Wakasa; Tomonori Ooka; Tsuyoshi Tachibana; Shigeyuki Sasaki; Yoshiro Matsui
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-06-15

9.  Catheter ablation for atrial fibrillation in patients with the Marfan and Marfan-like syndromes.

Authors:  T Jared Bunch; Heidi M Connolly; Samuel J Asirvatham; Peter A Brady; Bernard J Gersh; Thomas M Munger; Win-Kuang Shen; Kristi H Monahan; Douglas L Packer
Journal:  J Interv Card Electrophysiol       Date:  2007-10-20       Impact factor: 1.900

10.  Single-centre experience with mitral valve repair in asymptomatic patients with severe mitral valve regurgitation.

Authors:  Wouter J van Leeuwen; Stuart J Head; Lotte E de Groot-de Laat; Marcel L Geleijnse; Ad J J C Bogers; Lex A Van Herwerden; A Pieter Kappetein
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.